Full text is available at the source.
Abstract
Prescription behaviors for injectable semaglutide may influence early discontinuation rates.
- Glucagon-like peptide-1 receptor agonists (GLP-1RA) are increasingly used but little is understood about their initiation in everyday clinical settings.
- High rates of discontinuation for semaglutide have been observed in routine care.
- Prescribing behaviors at the start of treatment could be linked to medication persistence after one year.
- Further investigation is needed to understand the factors contributing to discontinuation during treatment.
Simplified